About TERUMO
TERUMO is a company based in Tokyo (Japan) founded in 1921. The company has 148 employees as of April 07, 2024.
- Headquarter Tokyo, Japan
- Employees 148 as on 07 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Terumo India Private Limited
- Date of Incorporation 15 Jul, 2013
- Jurisdiction Sadar Bazar, Haryana, India
-
Annual Revenue
$50.56 M (USD)27.66as on Mar 31, 2023
-
Net Profit
$3.19 M (USD)34.48as on Mar 31, 2023
-
EBITDA
$4.22 M (USD)35.11as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
148
as on Apr 07, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of TERUMO
TERUMO is a publicly listed company on the TSE with ticker symbol 4543 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of TERUMO
Unlock access to complete
Unlock access to complete
Funding Insights of TERUMO
Detailed funding history for TERUMO
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by TERUMO
Investment portfolio details for TERUMO
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - TERUMO
Detailed financials for TERUMO
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Terumo Comparisons
Peer comparison for TERUMO
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of TERUMO
Detailed competitors of TERUMO
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Terumo
Complete news archive for TERUMO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TERUMO
TERUMO was founded in 1921.
TERUMO is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
Nakao Koji is the current CEO of TERUMO.
As of Apr 07, 2024, the latest employee count at TERUMO is 148.
Annual revenue of TERUMO is $50.56M as on Mar 31, 2023.
Terumo Corporation was founded in 1921 in Tokyo, Japan, and operates in the medical equipment manufacturing sector. Products such as intravenous catheters, infusion sets, artificial heart and lung systems, blood glucose monitors, and blood pressure monitoring devices are produced. Business activities are conducted in regions including Europe, South America, China, India, the Philippines, and Australia. In 2022, annual revenues of 6.07 billion and net profit of 0.66 billion were recorded.
Yes, TERUMO is publicly traded on TSE under the ticker symbol 4543.
The ticker symbol of TERUMO is 4543 on TSE.